Literature DB >> 34260558

Association of vitamin D receptor gene polymorphism with type 1 diabetes mellitus risk in children: A protocol for systematic review and meta-analysis.

Yalin Ran1, Suyuan Hu1, Xiaohua Yu2, Renjun Li2.   

Abstract

BACKGROUND: Recent genetic association studies showed that there are contradictory results on the relationship between vitamin D receptor (VDR) gene polymorphisms and type 1 diabetes mellitus (T1DM) risk in children. The purpose of this systematic review is to collect the currently available evidence to evaluate the relationship between VDR gene polymorphisms and the risk of T1DM in children.
METHODS: Such medical databases as Wanfang Data, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, Chongqing VIP Chinese Science and Technology Periodical Database, PubMed, Embase, and Web of Science were extensively searched for relevant literatures published before June 2021 with the focus on the relationship between VDR gene polymorphisms and the risk of T1DM in children. The risk of bias was evaluated as per the Newcastle-Ottawa Scale by 2 independent researchers. Meta-analysis was performed to quantify the relationship between VDR gene polymorphisms and T1DM risk in children.
RESULTS: The results of this meta-analysis would be submitted to a peer-reviewed journal for publication.
CONCLUSION: The relationship between VDR gene polymorphisms and T1DM risk in children is explored via this meta-analysis. ETHICS AND DISSEMINATION: Ethical approval was not required for this study. The systematic review will be published in a peer-reviewed journal, presented at conferences, and shared on social media platforms. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/Q8XA5.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34260558      PMCID: PMC8284714          DOI: 10.1097/MD.0000000000026637

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Type 1 diabetes mellitus (T1DM) refers to an autoimmune disease that is mainly mediated by T cell immunity, and its pathogenesis is very complex.[ T1DM accounts for approximately 5% to 10% of all diabetes cases, and its prevalence is still on the rise.[ As is known to all, T1DM is a multi-factorial autoimmune disease induced by the interaction of genetic and environmental factors.[ In recent years, many genes related to T1DM have received extensive attention. It has been demonstrated in abundant studies that vitamin D may exert significant impacts on the pathogenesis of T1DM through vitamin D receptor (VDR) gene.[ Besides, it has been suggested in some studies that vitamin D deficiency is associated with the autoimmune destruction of β cells and the onset of T1DM induced by loss of immune regulation.[ Vitamin D has a protective effect on T1DM.[ Dietary vitamin D intake in early childhood could reduce the risk of T1DM.[ In addition, vitamin D supplementation during pregnancy may prevent the development of islet cell autoantibodies in newborns.[ Vitamin D could exert its actions via a nuclear vitamin D receptor (VDR).[ Therefore, the VDR gene can be considered a candidate/predisposing gene for T1DM. In recent years, it has been demonstrated in related studies that VDR gene polymorphism may be associated with the genetic predisposition to T1DM. However, the relationship between VDR gene polymorphism and the risk of T1DM in children has not been confirmed yet, and there are contradictory results on such relationship.[ Therefore, the purpose of this study is to further verify the relationship between VDR gene polymorphism and the risk of T1DM in children by collecting relevant literature.

Methods

Study registration

The protocol of this review was registered in OSF (OSF registration number: DOI 10.17605/OSF.IO/Q8XA5). It was reported in accordance with the statement guidelines of preferred reporting items for systematic reviews and meta-analyzes protocol.[

Inclusion criteria

All eligible studies included in this study shall fulfill these inclusion criteria: studies with the focus on the relationship between VDR gene polymorphisms and the risk of T1DM; participants with the age less than 18 years old; studies with sufficient data to calculate the odds ratio (OR) and its 95% confidence intervals (CIs); case-control or cohort studies.

Exclusion criteria

The exclusion criteria were: letters, case reports, meta-analysis, review papers, papers without a control group, literature with abstract only, and literature without detailed genotype data.

Search strategy

Medical databases (Wanfang Data, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, Chongqing VIP Chinese Science and Technology Periodical Database, PubMed, Embase, and Web of Science) were systematically searched for papers published before June 2021 with respect to the relationship between VDR gene polymorphisms and the risk of T1DM in children. The search strategy for PubMed is presented in Table 1, and the corresponding keywords would be employed in other databases.
Table 1

Search strategy for PubMed.

NumberSearch terms
#1Diabetes Mellitus, Type 1[MeSH]
#2Diabetes Mellitus, Brittle[Title/Abstract]
#3Diabetes Mellitus, Insulin-Dependent[Title/Abstract]
#4Diabetes Mellitus, Juvenile-Onset[Title/Abstract]
#5Diabetes Mellitus, Ketosis-Prone[Title/Abstract]
#6Diabetes Mellitus, Sudden-Onset[Title/Abstract]
#7Diabetes, Autoimmune[Title/Abstract]
#8IDDM[Title/Abstract]
#9Autoimmune Diabetes[Title/Abstract]
#10Diabetes Mellitus, Insulin-Dependent, 1[Title/Abstract]
#11Diabetes Mellitus, Type I[Title/Abstract]
#12Insulin-Dependent Diabetes Mellitus 1[Title/Abstract]
#13Juvenile-Onset Diabetes[Title/Abstract]
#14Type 1 Diabetes Mellitus[Title/Abstract]
#15Brittle Diabetes Mellitus[Title/Abstract]
#16Diabetes Mellitus, Insulin Dependent[Title/Abstract]
#17Diabetes Mellitus, Juvenile Onset[Title/Abstract]
#18Diabetes Mellitus, Ketosis Prone[Title/Abstract]
#19Diabetes Mellitus, Sudden Onset[Title/Abstract]
#20Diabetes, Juvenile-Onset[Title/Abstract]
#21Insulin Dependent Diabetes Mellitus 1[Title/Abstract]
#22Insulin-Dependent Diabetes Mellitus[Title/Abstract]
#23Juvenile Onset Diabetes[Title/Abstract]
#24Juvenile-Onset Diabetes Mellitus[Title/Abstract]
#25Ketosis-Prone Diabetes Mellitus[Title/Abstract]
#26Mellitus, Sudden-Onset Diabetes[Title/Abstract]
#27Sudden-Onset Diabetes Mellitus[Title/Abstract]
#28or/1-27
#29Child[MeSH]
#30Child∗[Title/Abstract]
#31or/29-30
#32Receptors, Calcitriol[MeSH]
#33Calcitriol Receptors[Title/Abstract]
#34Cholecalciferol Receptors[Title/Abstract]
#35Receptors, Vitamin D[Title/Abstract]
#36Vitamin D 3 Receptors[Title/Abstract]
#37Vitamin D Receptors[Title/Abstract]
#381,25-Dihydroxycholecalciferol Receptor[Title/Abstract]
#391,25-Dihydroxycholecalciferol Receptors[Title/Abstract]
#401,25-Dihydroxyvitamin D 3 Receptor[Title/Abstract]
#411,25-Dihydroxyvitamin D3 Receptor[Title/Abstract]
#421,25-Dihydroxyvitamin D3 Receptors[Title/Abstract]
#43Calcitriol Receptor[Title/Abstract]
#44Receptors, 1,25-Dihydroxyvitamin D 3[Title/Abstract]
#45Receptors, Cholecalciferol[Title/Abstract]
#46Receptors, Vitamin D 3[Title/Abstract]
#47Receptors, Vitamin D3[Title/Abstract]
#48Vitamin D 3 Receptor[Title/Abstract]
#49Vitamin D Receptor[Title/Abstract]
#50Vitamin D3 Receptor[Title/Abstract]
#51Vitamin D3 Receptors[Title/Abstract]
#521,25 Dihydroxycholecalciferol Receptor[Title/Abstract]
#531,25 Dihydroxycholecalciferol Receptors[Title/Abstract]
#541,25 Dihydroxyvitamin D 3 Receptor[Title/Abstract]
#551,25 Dihydroxyvitamin D3 Receptor[Title/Abstract]
#561,25 Dihydroxyvitamin D3 Receptors[Title/Abstract]
#57D Receptor, Vitamin[Title/Abstract]
#58D Receptors, Vitamin[Title/Abstract]
#59D3 Receptor, 1,25-Dihydroxyvitamin[Title/Abstract]
#60D3 Receptor, Vitamin[Title/Abstract]
#61D3 Receptors, 1,25-Dihydroxyvitamin[Title/Abstract]
#62D3 Receptors, Vitamin[Title/Abstract]
#63Receptor, 1,25-Dihydroxycholecalciferol[Title/Abstract]
#64Receptor, 1,25-Dihydroxyvitamin D3[Title/Abstract]
#65Receptor, Calcitriol[Title/Abstract]
#66Receptor, Vitamin D[Title/Abstract]
#67Receptor, Vitamin D3[Title/Abstract]
#68Receptors, 1,25-Dihydroxycholecalciferol[Title/Abstract]
#69Receptors, 1,25-Dihydroxyvitamin D3[Title/Abstract]
#70or/32–69
#71Polymorph∗[Title/Abstract]
#72Susceptibility[Title/Abstract]
#73or/71–72
#74#28 and #31 and #70 and #73
Search strategy for PubMed.

Data collection and analysis

Selection of literature

Two researchers independently screened the literature for data extraction and cross-checking. If there are differences, the discussion or consultation with a third party would be required. During the screening process, the title was read at first in an attempt to exclude the obviously irrelevant literature, followed by the abstract and the full text to determine its eligibility. The flowchart is presented in Figure 1.
Figure 1

Flow chart of literature search and screen.

Flow chart of literature search and screen.

Data extraction

The following data were independently extracted by 2 researchers: first author, year of publication, country of origin, ethnicity, number of cases and controls, genotype frequency, source of controls, age, genotyping method, sample size, and Hardy-Weinberg equilibrium (HWE).

Methodology quality assessment

The quality assessment of the included literature was investigated based on Newcastle-Ottawa Scale.[ Those with a score of 6 would be considered to be of high quality.[

Dealing with missing data

In case of any missing data in a literature, please contact the newsletter author or the first author by email for accurate data. If there is a failure in the data request, descriptive analysis, instead of meta-analysis, shall be conducted.

Statistical analysis

In each included literature, HWE was examined to assess bias in genotype distribution. Besides, odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for analyzes of the VDR gene polymorphisms and T1DM risk in children. In addition, the pooled ORs and 95% CIs were calculated in 5 genetic models, namely allele model (T vs C), heterozygote model (TC vs CC), homozygote model (TT vs CC), dominant model (TT + TC vs CC), and recessive model (TT vs TC + CC). Moreover, the heterogeneity was calculated with the Chi-Squared-based I2 test and the Q test. If the I2 value is less than 50%, the fixed-effect model would be adopted. If the I2 value is more than 50%, a random-effects model would be adopted. All of the statistical analyzes were conducted by the STATA 16.0 (StataCorp, College Station, TX, USA), and the P values were two-sided.

Subgroup analysis

According to ethnicity, source of controls and genotyping method, the subgroup analysis was performed on the relationship between VDR gene polymorphisms and the risk of T1DM in children.

Sensitivity analysis

The eligible papers were sequentially removed in order to perform the sensitivity analysis.

Assessment of publication biases

Potential publication bias was estimated by Egger linear regression test, and Begg test was employed to estimate the funnel plot asymmetry.[

Ethics and dissemination

The content of this article does not involve moral approval or ethical review and would be presented in print or at relevant conferences.

Discussion

The VDR gene located at 12q13 consists of 9 exons and 8 introns, with multiple restriction endonuclease restriction sites. The common loci include BSM I, Apai, Taqi, and Foki.[ VDR gene polymorphisms have been associated with susceptibility to a variety of autoimmune diseases over the past few decades.[ In recent years, the relationship between VDR gene polymorphisms and T1DM has been investigated in several studies around the world. However, there is no meta-analysis of VDR polymorphism and the risk of T1DM in children. Meanwhile, the relationship between VDR gene polymorphisms and the risk of T1DM in children reported in the existing literature is inconsistent. In addition, the risk of T1DM is increasing due to vitamin D deficiency from year to year.[ Therefore, a comprehensive meta-analysis may be the optimal way to address these problems.

Author contributions

Conceptualization: Renjun Li, Yalin Ran. Data curation: Suyuan Hu. Funding acquisition: Renjun Li. Formal analysis: Xiaohua Yu. Investigation: Suyuan Hu. Methodology: Yalin Ran. Project administration: Renjun Li. Resources: Xiaohua Yu. Software: Xiaohua Yu. Supervision: Renjun Li. Validation: Yalin Ran. Visualization and software: Yalin Ran. Writing – original draft: Yalin Ran and Renjun Li. Writing – review & editing: Yalin Ran and Renjun Li.
  32 in total

1.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

2.  Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population.

Authors:  T J Chang; H H Lei; J I Yeh; K C Chiu; K C Lee; M C Chen; T Y Tai; L M Chuang
Journal:  Clin Endocrinol (Oxf)       Date:  2000-05       Impact factor: 3.478

Review 3.  1,25-Dihydroxyvitamin D3--a hormone with immunomodulatory properties.

Authors:  J Lemire
Journal:  Z Rheumatol       Date:  2000       Impact factor: 1.372

4.  Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group.

Authors: 
Journal:  Diabetologia       Date:  1999-01       Impact factor: 10.122

5.  Vitamin D receptor (VDR) gene polymorphisms and age onset in type 1 diabetes mellitus.

Authors:  Jaqueline De Azevêdo Silva; Rafael Lima Guimarães; Lucas André Cavalcanti Brandão; Jacqueline Araujo; Ludovica Segat; Sergio Crovella; Paula Sandrin-Garcia
Journal:  Autoimmunity       Date:  2013-05-30       Impact factor: 2.815

6.  Evaluation of vitamin D receptor gene polymorphisms (Fok-I and Bsm-I) in T1DM Saudi children.

Authors:  Rabab Ali; Iman Fawzy; Ihsan Mohsen; Ahmad Settin
Journal:  J Clin Lab Anal       Date:  2018-02-08       Impact factor: 2.352

Review 7.  A meta-analysis of association of vitamin D receptor BsmI gene polymorphism with the risk of type 1 diabetes mellitus.

Authors:  Wei-Hong Qin; Han-Xiao Wang; Jun-Lin Qiu; Xue-Bin Huang; Yan Huang; Nian-Rong Wu; Hua-Sheng Liang
Journal:  J Recept Signal Transduct Res       Date:  2014-03-25       Impact factor: 2.092

8.  Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children.

Authors:  Somia H Abd-Allah; Heba F Pasha; Hoda A Hagrass; Ashgan A Alghobashy
Journal:  Gene       Date:  2013-12-23       Impact factor: 3.688

9.  Vitamin D receptor gene TaqI and Apal polymorphisms and steroid responsiveness in childhood idiopathic nephrotic syndrome.

Authors:  Amal A Al-Eisa; Mohammad Z Haider
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-08-05

10.  Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child.

Authors:  Maija E Miettinen; Melissa C Smart; Leena Kinnunen; Valma Harjutsalo; Linnea Reinert-Hartwall; Irene Ylivinkka; Heljä-Marja Surcel; Christel Lamberg-Allardt; Graham A Hitman; Jaakko Tuomilehto
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.